
Sign up to save your podcasts
Or
Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.
4.9
3434 ratings
Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.
273 Listeners
35 Listeners
488 Listeners
264 Listeners
3,312 Listeners
250 Listeners
90 Listeners
1,069 Listeners
169 Listeners
345 Listeners
506 Listeners
239 Listeners
409 Listeners
365 Listeners
75 Listeners